Filing Flows › International Stem Cell (ISCO) › Biomedical Market revenue
International Stem Cell (ISCO) Biomedical Market revenue by quarter
International Stem Cell's Biomedical Market revenue was $2.5M in Q2 2026 (second quarter 2026), +16% from Q1 2026. Over the last 7 quarters it ranged from $2.0M (Q1 2025) to $2.5M (Q2 2026).
| Quarter | Biomedical Market revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $2.5M | +16% | +10% |
| Q1 2026 | $2.2M | +8% | +9% |
| Q4 2025 | $2.0M | -9% | -11% |
| Q3 2025 | $2.2M | -4% | — |
| Q2 2025 | $2.3M | +15% | — |
| Q1 2025 | $2.0M | -11% | — |
| Q4 2024 | $2.2M | — | — |
Q2 2026 at a glance
International Stem Cell, Q2 2026: revenue $2.7M (+9% year over year), operating margin -1.3%, net loss $71K, operating cash flow $167K. The chart follows the revenue to costs, profit and cash.
Questions
What is International Stem Cell's Biomedical Market revenue?
International Stem Cell's Biomedical Market revenue was $2.5M in Q2 2026 (second quarter 2026), +16% from Q1 2026.
How has International Stem Cell's Biomedical Market revenue changed?
Over the last 7 quarters it ranged from $2.0M (Q1 2025) to $2.5M (Q2 2026).
Q2 2026 results → · How International Stem Cell makes money →